Issue Title Abstract File
Vol 13, No 4 (2011) 17 noyabrya 2011 g. v ramkakh X Natsional'nogoonkologicheskogo kongressa sostoyalsyasimpozium «Biosimilyary: novye gorizontyrazvitiya zdravookhraneniya» Abstract
- -.
Vol 14, No 3 (2012) 22 sentyabrya 2012 g. sostoyalsya press-brifing, posvyashchennyy roli targetnoy terapii v preodolenii lekarstvennoy rezistentnosti pri lechenii metastaticheskogo raka molochnoy zhelezy (mRMZh) i, v chastnosti, predstavleniyu obshchestvennosti novykh zaregistrirovannykh pokazaniy dlya primeneniya preparata Afinitor pri mRMZh Abstract
- -.
Vol 12, No 4 (2010) 25 noyabrya 2010 g. «AstraZeneka Rossiya» ob\"yavilapromezhutochnye rezul'taty issledovaniya EPICLIN Abstract
- -.
Vol 14, No 3 (2012) 6-9 sentyabrya 2012 g. v Marsele sostoyalsya 10-y kongress Evropeyskoy assotsiatsii po neyroonkologii (EANO) Abstract
Absalyamova O.V.
Vol 10, No 1 (2008) 8 let nadezhdy: novye dannye issledovaniya ATAS Abstract
- -.
Vol 20, No 4 (2018) A method of laparoscopic installation of port systems for intra-abdominal chemotherapy in patients with advanced ovarian cancer Abstract PDF
(Rus)
Lozovaya V.V., Cherkes L.V., Malikhova O.A., Poddubny B.K.
Vol 17, No 1 (2015) A population-based portrait of breast cancer in russia: a cancer register-based analysis in russian Abstract
Poddubnaya I.V., Kolyadina I.V., Kalashnikov N.D., Borisov D.A., Makarova M.V.
Vol 17, No 3 (2015) Adenosquamous carcinoma of the colon: case report Abstract
Nefedova N.A., Kharlova O.A., Malkov P.G., Kharlov N.S., Danilova N.V.
Vol 9, No 2 (2007) Ad\"yuvantnaya endokrinoterapiya postmenopauzal'nykh bol'nykh rakom molochnoy zhelezy Abstract
Semiglazov V.F., Semiglazov V.V.
Vol 3, No 2 (2001) Ad\"yuvantnaya khimioterapiya raka molochnoy zhelezy: ot alkiliruyushchikh preparatov i antimetabolitov k antratsiklinam i taksonam Abstract
Voznyy E.K.
Vol 11, No 4 (2009) Ad\"yuvantnaya terapiyav lechenii gastrointestinal'nykh stromal'nykh opukholey Abstract
Nikulin M.P., Stilidi I.S.
Vol 10, No 1 (2008) Ad\"yuvantnoe lechenie raka tolstoy kishki Abstract
Artamonova E.V., Podregul'skiy K.E.
Vol 17, No 3 (2015) Afatinib versus erlotinib as second-line treatment of patients with advanced squamous cell carcinoma of the lung (LUX-Lung 8): an open-label randomised controlled phase 3 trial Abstract
Soria J., Felip E., Cobo M., Lu S., Syrigos K., Lee K.H., Göker E., Georgoulias V., Li W., Isla D., Guclu S.Z., Morabito A., Min Y.J., Ardizzoni A., Gadgeel S.M., Wang B., Chand V.K., Goss G.D.
Vol 3, No 4 (2001) Aktivatory plazminogena urokinaznogo i tkanevogo tipov i ikh ingibitor pervogo tipa pri rake pishchevoda (predvaritel'nye rezul'taty) Abstract
Gershteyn E.S., Goncharov D.Y., Kushlinekiy N.E., Poddubnaya I.V.
Vol 12, No 4 (2010) Aktivnaya khirurgicheskaya taktikav sovremennom algoritme lecheniyarasprostranennogo raka yaichnika Abstract
Pokataev I.A., Stenina M.B., Tyulyandina A.S., Tyulyandin S.A.
Vol 2, No 1 (2000) Aktual'nye voprosy limfodissektsii u bol'nykh rakom grudnogo otdela pishchevoda Abstract
Davydov M.I., Stilidi I.S., Arzykulov D.A., Ter-Ovanesov M.D., Godzhamanov Y.G., Lagoshnyy A.T.
Vol 19, No 1 (2017) Albumin-bound paclitaxel in the treatment of metastatic breast cancer Abstract PDF
(Rus)
Artamonova E.V.
Vol 16, No 2 (2014) Algorithm of treatment of patients with castrate-resistant prostate cancer: modern concept and perspectives Abstract
Alekseev B.Y., Nyushko K.M., Kalpinskiy A.S., Kaprin A.D.
Vol 12, No 1 (2010) Alimta (pemetreksed) v pervoylinii lecheniya disseminirovannogonemelkokletochnogo raka legkogo Abstract
Bychkov M.B., Bol'shakova S.A., Bychkov Y.M.
Vol 13, No 3 (2011) Allel'nye varianty v genakh BRCA1,BRCA2, TP53, assotsiirovannyes razvitiem raka molochnoy zhelezy Abstract
Sytenkova K.V., Guzieva Z.M., Kazakov M.P., Lyubchenko L.N., Poddubnaya I.V.
Vol 9, No 2 (2007) Ambulatornoe lechenie khronicheskogo limfoleykoza: doma i steny pomogayut v ramkakh mezhdunarodnogo meditsinskogo simpoziuma «Rekomenduy svobodu!» Abstract
- -.
Vol 12, No 4 (2010) Analiz bazovykh issledovaniy III fazy podtverzhdaetpreimushchestvo denosumaba pered standartnoy terapieyu bol'nykh s metastaticheskim porazheniem kostey Abstract
- -.
Vol 6, No 4 (2004) Analiz lecheniya onkoginekologicheskikh opukholey v Yakutii Abstract
Kipriyanova N.S., Afanas'eva L.N., Aksel' E.M., Poddubnaya I.V.
Vol 7, No 1 (2005) Analiz rezul'tatov vnedreniya Regional'noy rossiyskoy programmy lecheniya pervichno-generalizovannogo i metastaticheskogo raka molochnoy zhelezy v Voronezhskom oblastnom klinicheskom onkologicheskom dispansere Abstract
Chevardov N.I., Tolstykh L.V., Puzakov K.G., Potapov Y.N.
Vol 5, No 3 (2003) Analiz sostoyaniya onkoginekologicheskoy pomoshchi naseleniyu v Respublike Sakha (Yakutiya) Abstract
Aksel' E.M., Afanas'eva L.N., Kipriyanova N.S., Smetanina V.D., Poddubnaya I.V.
Vol 8, No 3 (2006) Analiz sostoyaniya onkoginekologicheskoy pomoshchi v navoiyskom regione (Respublika Uzbekistan) Abstract
Kudryavtsev I.Y., Kerimov R.A.
Vol 5, No 3 (2003) Analiz sostoyaniya onkologicheskoy pomoshchi v Respublike Sakha (Yakutiya) za 1991-2001 gg Abstract
Poddubnaya I.V., Aksel' E.M., Kipriyanova N.S.
Vol 13, No 3 (2011) Analiz zabolevaemosti rakommolochnoy zhelezy s uchetom statusa HER2na territorii Rossiyskoy Federatsii Abstract
Ryazhenov V.V., Gorokhova S.G.
Vol 10, No 2 (2008) ANAPLASTIChESKAYa KRUPNOKLETOChNAYa LIMFOMA VZROSLYKh:VLIYaNIE PROGNOSTIChESKIKh FAKTOROV NA TERAPIYu Abstract
Semenova A.A., Sorokin E.N., Poddubnaya I.V., Probatova N.A., Timofeeva O.L.
Vol 4, No 1 (2002) Anastrozol kak perspektiva ad\"yuvantnogo lecheniya raka molochnoy zhelezy u bol'nykh v menopauze Abstract
Gorbunova V.A.
Vol 12, No 3 (2010) Anemiya i sposoby ee korrektsiiu onkologicheskikh bol'nykh Abstract
Babicheva L.G., Poddubnaya I.V.
Vol 4, No 3 (2002) Anemiya pri zlokachestvennykh opukholyakh Abstract
Breder V.V., Gorbunova V.A., Besova N.S.
Vol 13, No 2 (2011) Anemiya pri zlokachestvennykhnovoobrazovaniyakh: printsipy terapii Abstract
Gorokhovskaya G.N., Petina M.M.
Vol 14, No 1 (2012) Anemiya v onkologii:podkhody k lecheniyu Abstract
Ptushkin V.V.
Vol 16, No 2 (2014) Angiogenesis as a target for cancer therapy Abstract
Imyanitov E.N.
Vol 15, No 3 (2013) Antiangiogennaya terapiya disseminirovannogo kolorektal'nogo raka Abstract
Meshcheryakov A.A.
Vol 14, No 2 (2012) Antiangiogennaya terapiya v lechenii glioblastomy: obzor i sobstvennye klinicheskie dannye Abstract
Kobyakov G.L., Absalyamova O.V., Urakov S.V., Smolin A.V., Strazhev S.V.
Vol 13, No 4 (2011) Antiangiogennaya terapiyapri rake molochnoy zhelezys troynym negativnym fenotipom Abstract
Zhukova L.G.
Vol 2, No 1 (2000) Antiemetogennaya terapiya ondasetronom pri polikhimioterapii zlokachestvennykh opukholey u devochek Abstract
Safonova S.A., Punanov Y.A., Kolygin B.A.
Vol 9, No 1 (2007) Antiestrogennaya terapiya pri rake molochnoy zhelezy. Naskol'ko bezopasny ingibitory aromatazy? Abstract
Ptushkin V.V.
Vol 19, No 1 (2017) Anxiety and cognitive impairment in elderly patients with gastrointestinal cancers Abstract PDF
(Rus)
Stilidi I.S., Kotyukova A.Y., Lyadov V.K.
Vol 2, No 1 (2000) Arimideks - novyy nesteroidnyy selektivnyy ingibitor aromatazy Predvaritel'nye rezul'taty "Otkrytogo nesravnitel'nogo issledovaniya po otsenke effektivnosti i perenosimosti arimideksa ( 1 mg) pri lechenii rasprostranennogo raka molochnoy zhelezy u zhenshchin Abstract
Gorbunova V.A., Gorin A.M., Odintsov S.V., Kozlov D.V., Vychkov M.V., Dobrovol'skaya N.Y., Vazin I.G., Meshcheryakov A.A.
Vol 5, No 4 (2003) Arimideks (anastrozol) v sravnenii s tamoksifenom v neoad\"yuvantnoy endokrinoterapii bol'nykh rakom molochnoy zhelezy Abstract
Semiglazov V.F., Zhil'tsova E.K., Semiglazov V.V., Ivanov V.G., Dashyan G.A., Klettsel' A.A., Bozhok A.A., Nurgaziev K.S., Topuzov E.E., Krivorot'ko P.V., Tsyrlina E.V., Bershteyn L.M.
Vol 3, No 4 (2001) Arimideks: novye vozmozhnosti v lechenii generalizovannogo raka molochnoy zhelezy Abstract
Borisov V.I.
Vol 7, No 2 (2005) Aromazin (ekzemestan) v neoad\"yuvantnoy i ad\"yuvantnoy gormonoterapii raka molochnoy zhelezy Abstract
Makarenko N.P.
Vol 11, No 4 (2009) Aromazin v ad\"yuvantnoy terapii raka molochnoy zhelezy Abstract
Artamonova E.V.
Vol 7, No 3 (2005) Aromazin: printsip deystviya Abstract
Imyanitov E.N.
Vol 13, No 3 (2011) ASCO 2011: novye standartyv lechenii stromal'nykh opukholeyzheludochno-kishechnogo trakta Abstract
Nikulin M.P.
Vol 10, No 2 (2008) ASCO Innovatsionnye metody bor'by s onkologicheskimi zabolevaniyam Abstract
- -.
Vol 12, No 3 (2010) Astenicheskie rasstroystva,assotsiirovannye s khimioterapieyzlokachestvennykh novoobrazovaniy(Obzor literatury) Abstract
Shafigullin M.R., Ivanov S.V., Gorbunova V.A., Meshcheryakov A.A.
Vol 7, No 2 (2005) Astrotsitomy nizkoy stepeni zlokachestvennosti polushariy bol'shogo mozga Abstract
Aleshin V.A., Karakhan V.B.
Vol 17, No 3 (2015) Atsellbiya® - opyt primeneniya pervogo bioanaloga rituksimaba v rutinnoy praktike klinitsista Abstract
- -.
Vol 18, No 5 (2016) Autologous stem cells transplantation in the first remission of follicular lymphoma as "rescue therapy" in patients with unfavorable prognosis factors. The first prospective study results Abstract
Nesterova E.S., Kravchenko S.K., Baryakh E.A., Misyurina A.E., Mangasarova Y.K., Vorobev V.I., Chernova N.G., Gemdzhian E.G., Savchenko V.G.
Vol 16, No 3 (2014) Avastin in clinical chemotherapy of malignant tumors Abstract
Gorbunova V.A.
Vol 19, No 3 (2017) BCD-100 - first russian PD-1 inhibitor Abstract PDF
(Rus)
Tyulyandin S.A., Fedyanin M.Y., Semiglazova T.Y., Moiseenko V.M., Odintsova S.V., Alekseev B.Y., Ivanov R.A., Shustova M.S.
Vol 14, No 2 (2012) Bendamustin v terapii nekhodzhkinskikh limfom Abstract
Semenova A.A.
Vol 20, No 4 (2018) Bendamustine in the treatment of B-cell non-Hodgkin lymphoma Abstract PDF
(Rus)
Babicheva L.G., Poddubnaya I.V.
Vol 16, No 3 (2014) Bevacizumab in advanced ovarian cancer: when, what for and why? Abstract
Tjulandina A.S.
Vol 11, No 1 (2009) Bevatsizumab (Avastin) v kombinatsii s taksanami v 1-y linii lecheniya HER-2-negativnogo metastaticheskogo raka molochnoy zhelezy(Rezul'taty issledovaniya AVADO) Abstract
Zhukova L.G.
Vol 12, No 1 (2010) Bevatsizumab pri metastaticheskomi retsidiviruyushchem rake molochnoy zhelezy:metaanaliz randomizirovannykh issledovaniy Abstract
Kolyadina I.V., Poddubnaya I.V.
Vol 15, No 3 (2013) Bevatsizumab v kombinatsii s khimioluchevoy terapiey u bol'nykh glioblastomoy Abstract
Smolin A.V., Konev A.V., Kobyakov G.L., Nikolaeva S.N., Shamanskaya Y.E., Gorbunov A.V.
Vol 15, No 3 (2013) Bevatsizumab v kombinatsii s khimioterapiey pri rake molochnoy zhelezy Abstract
Manzyuk L.V., Kovalenko E.I., Artamonova E.V., Osmanova L.I.
Vol 12, No 3 (2010) Bevatsizumab v lechenii HER2-negativnogometastaticheskogo raka molochnoy zhelezy:sovremennye dannye ob effektivnostii bezopasnosti Abstract
Zhukova L.G.
Vol 12, No 3 (2010) Bezopasnost' ibandronovoy kislotypri dlitel'nom primenenii Abstract
Semenov N.N.
Vol 18, No 2 (2016) Bioequivalence assessment of BCD-022 (trastuzumab, manufactured by JSC BIOCAD, Russia) as compared with Herceptin® (F.Hoffmann-La Roche Ltd., Switzerland), used in combination with paclitaxel in HER2-positive metastatic breast cancer patients: findings of the international, double-blind phase III clinical study Abstract PDF
(Rus)
Ignatova E.O., Burdaeva O.N., Kopp M.V., Kotiv B.N., Udovitsa D.P., Stroiakovskii D.L., Alekseev S.M., Sheveleva L.P., Khorinko A.V., Shapovalova I.S., Moiseenko V.M., Ivanov R.A.
Vol 7, No 2 (2005) Biologicheskie kharakteristiki opukholi (proliferativnaya aktivnost', ploidnost' i steroidnye retseptory) i ikh vliyanie na neposredstvennye i otdalennye rezul'taty lecheniya zapushchennogo raka molochnoy zhelezy Abstract
Nikolaeva T.G., Vyshinskaya G.V., Rotobel'skaya L.E.
Vol 13, No 4 (2011) Biosimilyary: novye vozmozhnostisovremennoy lekarstvennoy terapiiopukholey Abstract
Poddubnaya I.V.
Vol 10, No 3 (2008) Bondronat v forme dlya priema vnutr' effektiven u bol'nykh s kostnymi metastazami raka molochnoy zhelezy. Opyt odnogo tsentra Abstract
Semenov N.N., Lichinitser M.R., Vyshinskaya G.V., Meshcheryakov A.A., Novikov V.V., Gutorov S.L., Borisova E.I., Nakhalova T.A., Mikhina Z.P., Lyubimova N.V., Chaklina E.A., Aplevich N.N.
Vol 15, No 4 (2013) Bone mineral density in patient with breast cancer Abstract
Poddubnaya I.V., Kizhaev E.V., Kolyadina I.V., Banov S.M., Zhmaeva E.M., Secko M.A.
Vol 19, No 2 (2017) Brachytherapy with ultrasound assistance in patients with cervical cancer Abstract PDF
(Rus)
Kizhaev Y.E., Razumova E.L., Bessolova O.V.
Vol 17, No 2 (2015) Brain metastases in her2-positive breast cancer: new opportunities for systemic therapy Abstract
Artamonova E.V., Manziuk L.V.
Vol 18, No 1 (2016) BRCA-associated ovarian cancer (the experience of the Chemotherapy Department in N.N.Blokhin Russian Cancer Research Center of the Ministry of Health of Russia) Abstract PDF
(Rus)
Khokhlova S.V., Gorbunova V.A., Lyubchenko L.N., Imyanitov E.N.
Vol 17, No 1 (2015) Breast cancer immunology: theory and prospects (review) Abstract
Kolyadina I.V., Poddubnaya I.V.
Vol 15, No 2 (2013) Breast cancer: from guidelines to personalized oncology Abstract
PierFranco C., Valentina G.
Vol 18, No 2 (2016) Brentuximab vedotin in the treatment of relapsed and refractory forms of Hodgkin lymphoma Abstract PDF
(Rus)
Demina E.A.
Vol 15, No 4 (2013) Brest cancer: international online cooperation on sharing experience Abstract
- -.
Vol 2, No 3 (2000) Bronkhoskopiya v diagnostike i lechenii opukholey trakheobronkhial'nogo stvola Abstract
Poddubnyy B.K., Ungiadze G.V., Belousova N.V., Polotskiy B.E., Kontsevaya A.Y., Alekseeva T.R., Kondrat'eva T.T.
Vol 20, No 2 (2018) Case studies on clinical experience of targeted therapy ribociclib in combination with letrozole in patients with hormone receptor-positive, human epidermal growth factor receptor 2-negative advanced breast cancer Abstract PDF
(Rus)
Frolova M.A., Kochetkova Y.I., Chubenko V.A., Volkov N.M., Moiseenko F.V., Garmarnik T.V., Ponomarenko D.M., Orlov A.E., Kostalanova Y.V., Makarycheva Y.Y., Nizegorodzeva A.A.
Vol 20, No 3 (2018) Catamnesis of pediatric thoracic and abdominal cancer survivours Abstract PDF
(Rus)
Mikhailova S.N., Zaeva G.E., Gavrilenko T.F., Sinyagina Y.V., Kazantsev A.P.
Vol 18, No 5 (2016) Characteristics of approach to the treatment of chronic pain in terminal cancer patients Abstract
Nevzorova D.V., Ibragimov A.N., Bakunina E.A.
Vol 17, No 3 (2015) Choice of anti-angiogenic agents in second-line treatment in patients with metastatic colon cancer: bevacizumab, aflibercept, ramucirumab (a literature review) Abstract
Fedyanin M.I.
Vol 18, No 3 (2016) Circulating tumor cell: biology, methods of isolation, clinical significance in breast cancer Abstract PDF
(Rus)
Nenahova Y.N., Lyadov V.K., Poddubnaya I.V.
Vol 17, No 3 (2015) Clinical and prognostic significance of matrix metalloproteinase-7 and vascular endothelium growth factor in patients with ovarian cancer Abstract
Knyazev R.I., Poddubnaya I.V., Bokin I.I., Barinov V.V.
Vol 19, No 4 (2017) Clinical and radiological evaluation the effectiveness of preoperative systemic therapy in different biological subtypes of breast cancer stages T1-3N0-1M0 Abstract PDF
(Rus)
Pavlikova O.A., Poddubnaya I.V., Kolyadina I.V., Abdullaev A.G., Komov D.V., Danzanova T.Y., Sinyukova G.T., Kozlov N.A., Ganshina I.P., Zhukova L.G., Aliyeva G.S., Kerimov R.A., Gordeeva O.O.
Vol 16, No 4 (2014) Clinical case long-term care of the patient with mCRPC Abstract
Zaborskiy I.N., Karjakin O.B.
Vol 19, No 4 (2017) Clinical cases of the treatment of metastatic colorectal cancer in Russia Abstract PDF
(Rus)
Goldberg V.E., Hasanova A.I., Shkuratova V.V., Belevich Y.V., Popova N.O., Simolina E.I., Vysockaya V.V., Dudnikova E.A., Kravchuk T.L., Minnabetdinova R.R., Nekrasova O.V.
Vol 16, No 1 (2014) Clinical cases of treatment of hepatocellular carcinoma Abstract
Lazarev S.A., Mamontov K.G., Manihas G.M., Antimonik N.Y.
Vol 20, No 1 (2018) Clinical cases of treatment of patients with advanced hepatocellular carcinoma Abstract PDF
(Rus)
Petkau V.V., Gladkov O.A., Filatov P.N., Raigorodskii M.V., Tarkhanov A.A., Klimushkin A.V., Nikitina L.Y.
Vol 15, No 4 (2013) Clinical example of the drug pazopanib as a targeted therapy in inoperable cancer of the kidney Abstract
Klimenko A.A., Ivanov S.A.
Vol 16, No 3 (2014) Clinical experience with abiraterone acetate application in patients with castration-resistant prostate cancer Abstract
Gridneva Y.V., Matveev V.B., Kupchan D.Z., Kalinin S.A., Peters M.V.
Vol 18, No 5 (2016) Clinical features and therapy of double-hit and double-expressor lymphomas Abstract
Baryakh E.A., Misyurina A.E., Kovrigina A.M., Obukhova T.N., Kravchenko S.K., Magomedova A.U., Zingerman B.V., Misyurina E.N., Poteshkina N.G., Lysenko M.A., Vorobev A.I.
Vol 20, No 3 (2018) Clinical prognostic factors of bilateral synchronous renal cancer Abstract PDF
(Rus)
Komarov M.I., Matveev V.B., Volkova M.I., Komarov I.G., Ridin V.A.
Vol 20, No 1 (2018) Clinical significance of the achievement of MRD-negativity in patients with chronic lymphocytic leukemia Abstract PDF
(Rus)
Mirolyubova Y.V., Stadnik E.A.
Vol 18, No 3 (2016) Clinico-economic evaluation of different treatment strategies in patients with non-small cell lung cancer and mutations in the EGFR gene Abstract PDF
(Rus)
Ryazhenov V.V., Gorokhova S.G.
Vol 19, No 2 (2017) Clinico-morphological predictors and treatment outcomes in cervical stump cancer Abstract PDF
(Rus)
Usmanova L.S., Kuznetsov V.V., Mustafina E.A., Barinov V.V., Bokin I.I., Knyazev R.I., Akhmedova M.D.
Vol 15, No 1 (2013) Combined and complex treatment options for patients with operable rectal cancer Abstract
Barsukov Y.A., Tkachev S.I., Mamedli Z.Z., Kuzmichev D.V., Aliev В.А., Kim D.F.
Vol 17, No 4 (2015) Comparative evaluation of the efficacy of an incomplete cytoreduction application in combination with systemic therapy and systemic therapy as mono-therapy in patients with metastatic clear-cell renal cell carcinomas Abstract
Borisov P.S., Orlova R.V., Shkolnik M.I., Karlov P.A.
Vol 21, No 3 (2019) Complex radiologic imaging of early breast cancer (literature review) Abstract PDF
(Rus)
Aliyeva G.S., Korzhenkova G.P., Kolyadina I.V.
Vol 18, No 1 (2016) Concerning selective neck dissections in oral squamous cell carcinoma Abstract PDF
(Rus)
Alymov Y.V., Podvyaznikov S.O., Mudunov A.M.
Vol 20, No 1 (2018) Cost-effectiveness analysis of ixabepilone use in monotherapy in patients with locally advanced and metastatic breast cancer resistant to treatment with anthracyclines, taxanes and capecitabin Abstract PDF
(Rus)
Kolbin A.S., Mosikyan A.A., Balykina Y.E., Proskurin M.A.
1 - 100 of 995 Items 1 2 3 4 5 6 7 8 9 10 > >> 

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies